In recent years, Baima town in Taizhou has vigorously revitalized idle factories and inefficient land use, achieving spatial reconstruction and industrial revitalization.
An oral phospholipid gel known as "Parishu", developed by Qianshan Medical Technology (Taizhou), has been approved for listing, bringing a new solution to cancer patients suffering from oral mucosal injury.
The Jiangsu Department of Housing and Urban-Rural Development has announced the 2026 demonstration projects focused on characteristic countryside construction, with one from Taizhou Medical High-tech Zone included in this initiative.
Jiangsu Weihe Biotechnology received good news that its independently developed human leukocyte antigen (HLA) genotyping test kit (fluorescence PCR method) has been approved for the market.